Publications by authors named "Ian Fentiman"

Claim this Profile
R
Risk factors for male breast cancer.
Ian S Fentiman

Am J Transl Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant treatment for male breast cancer.
Ian Stuart Fentiman

Transl Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic difficulties of men with breast cancer.
Ian S Fentiman

Breast J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial.
Mangesh A Thorat, Pauline M Levey, J Louise Jones, Sarah E Pinder, Nigel J Bundred, Ian S Fentiman

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma : Results from the UK/ANZ DCIS Trial.
Mangesh A Thorat, Pauline M Levey, J Louise Jones, Sarah E Pinder, Nigel J Bundred, Ian S Fentiman

Clin Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical options for male breast cancer.
Ian S Fentiman

Breast Cancer Res Treat· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral Inflammatory Pseudotumour of the Breast: A Case Report and Review of the Literature.
Mohsin Dani, Sarah Pinder, Ian Fentiman

Eur J Breast Health· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet needs of men with breast cancer.
Ian S Fentiman

Eur J Surg Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The endocrinology of male breast cancer.
Ian S Fentiman

Endocr Relat Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biology of male breast cancer.
Ian S Fentiman

Breast· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Male Mammary Maladies.
Ian S Fentiman

Eur J Breast Health· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative progesterone for obese women with breast cancer may improve survival.
Ian S Fentiman

Womens Health (Lond)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives.
Demetrios Moris, Michalis Kontos, Eleftherios Spartalis, Ian S Fentiman

Breast Care (Basel)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.
Jennifer C Melvin, Arnie D Purushotham, Hans Garmo, Sarah E Pinder, Ian S Fentiman

Br J Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family history of breast cancer and its association with disease severity and mortality.
Jennifer C Melvin, Wahyu Wulaningsih, Zac Hana, Arnie D Purushotham, Sarah E Pinder, Ian Fentiman

Cancer Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male breast cancer is not congruent with the female disease.
Ian S Fentiman

Crit Rev Oncol Hematol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time.
Jennifer C Melvin, Arnie D Purushotham, Hans Garmo, Sarah E Pinder, Ian S Fentiman

Br J Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma.
Panagiotis Karagiannis, Federica Villanova, Debra H Josephs, Isabel Correa, Mieke Van Hemelrijck, Ian Fentiman

Oncoimmunology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman

J Clin Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.
Gordon F Schwartz, Harry Bartelink, Harold J Burstein, Blake Cady, Luigi Cataliotti, Ian S Fentiman

Breast J· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
Cher M Dallal, Roslyn A Stone, Jane A Cauley, Roberta B Ness, Victor G Vogel, Ian S Fentiman

Int J Biol Markers· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of operable breast cancer in older women.
Ian S Fentiman

J R Soc Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which patients need an axillary clearance after sentinel node biopsy?
Anastasia Pazaiti, Ian S Fentiman

Int J Breast Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.
Saskia Litière, Gustavo Werutsky, Ian S Fentiman, Emiel Rutgers, Marie-Rose Christiaens

Lancet Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.
Gordon F Schwartz, Jorge Reis-Fihlo, Lajos Pusztai, Ian S Fentiman, Roland Holland

Cancer· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis